Connect with us

Hi, what are you looking for?

Sunday, Apr 20, 2025
Mugglehead Investment Magazine
Alternative investment news based in Vancouver, B.C.
Audacious and Golden Triangle open cannabis clinic in Thailand
Audacious and Golden Triangle open cannabis clinic in Thailand
Photo via Herbidus Medical Center

Business

Audacious and Golden Triangle open cannabis clinic in Thailand

Since opening in March, the firm says its clinic has already seen 800 patients

Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) — doing business as Audacious — says it’s partnered with Golden Triangle Health to open the first cannabis clinic in Thailand supported by an American operator.

Herbidus Medical Center opened its doors March 7 in Sukhumvit 13, Bangkok. The clinic has already seen close to 800 patients, according to Audacious.

Herbidus is among the first legal clinics to prescribe cannabis for government-approved treatment. Audacious will support the clinic with its expertise as well as white-label capabilities for product manufacturing.

Golden Triangle is owned by the Thai food manufacturer NR Instant Produce PCL, with a market cap close to $400 million.

“We believe that together, we can be one of the most important players in the Asian cannabis market, following our joint launch in the Asian CBD market earlier this year,” Golden Triangle co-founder Tom Kruesopon said in a statement.

Read more: Audacious says facility-building ALPS propped Q2 sales

Read more: Australis to help build massive produce facility in Kuwait

Audacious CEO Terry Booth says interest in medical cannabis is rising in Thailand, and his firm is looking forward to bringing cannabis expertise and leadership to the market.

“This is one of several initiatives that we are embarking on with Golden Triangle Health, which along with its parent company enjoys robust distribution channels across Thailand, as well as nimble and powerful white-label capabilities for cannabis product manufacturing,” he says.

Golden Health Triangle will receive support from Audacious chief science officer Jason Dyck, who is also a Canada Research Chair.

“This will leverage the years of research we have performed in Canada and other countries, including Dr. Dyck’s studies on one of the world’s largest databases of medical cannabis users to identify the primary reasons for medical cannabis authorization and the health outcomes of these patients,” Booth continues.

Read more: Why clinical cannabis research is so complex: Canada Research Chair Q&A

Read more: Terry Booth talks Aurora exit, new role as Australis CEO

 

Follow Mugglehead on Twitter

Like Mugglehead on Facebook

Follow Natalia Buendia Calvillo on Twitter

natalia@mugglehead.com

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

AI and Autonomy

This deal will generate short-term financial gains for the company while positioning Gorilla as a key player

AI and Autonomy

Qure.ai just showcased the capabilities of its AI-powered chest X-ray at the World Conference on Lung Cancer

Cannabis

Thailand’s Prime Minister intends to put cannabis back into the Category 5 Narcotics list

AI and Autonomy

The tech giant announced commitments valued at about US$4 billion for Malaysia, Indonesia and Thailand this week